Clinical Trials Logo

Benign Thyroid Nodule clinical trials

View clinical trials related to Benign Thyroid Nodule.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05132478 Completed - Thyroid Cancer Clinical Trials

The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer

Start date: November 17, 2021
Phase: N/A
Study type: Interventional

118 adults with benign thyroid nodules who were seen at a UW Health clinic for a fine needle biopsy and do not need surgery will be enrolled and can expect to be on study for a one-time visit of up to 60 minutes. Each participant will be randomized to watch one of two videos simulating a patient-surgeon discussion about treatment options for low-risk thyroid cancer with or without emotionally supportive statements.

NCT ID: NCT03566537 Completed - Quality of Life Clinical Trials

Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease

Start date: June 11, 2018
Phase:
Study type: Observational [Patient Registry]

To detect any changes in Quality of Life in patients with benign thyroid diseases who undergo thyroidectomy compared to patients with benign thyroid diseases and conservative treatment and healthy subjects.

NCT ID: NCT03535974 Completed - Clinical trials for Benign Thyroid Nodule

Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules

ESSAY
Start date: May 15, 2018
Phase: N/A
Study type: Interventional

Clinical trial with a double-blind, placebo-controlled, crossover design; enrolls approximately 30 euthyroid patients with benign thyroid nodules, who will receive for 6 weeks a spirulina-based supplement, and for another 6 weeks placebo. Thyroid ecography will be performed three times for each patient, and blood tests including TSH, free T4, free T3 and ceruloplasmin/Copper will also be performed 3 times for each patient. It is expected that a decrease in the thyroid nodules occurs with the supplement administration. Compared with placebo there will be a decrease of at least 20% in the volume or the largest diameter of the nodules during the 6-week administration of the supplement.